RetaMaps

Medi-Weightloss Chester

Medi-Weightloss Chester · 12200 Branders Creek Drive · Chester, VA 23831

4.9· 22 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • GLP-1 medications named on site
  • Medically supervised weight loss

About this practice

Medi-Weightloss Chester is a medical weight-loss clinic in Chester, Virginia, and part of the Medi-Weightloss network. Its website positions its weight loss care as physician-led and tailored to the individual, and it counts more than 130 locations across the US. Listed services in Chester include semaglutide and tirzepatide, IV therapy and telehealth visits. Chester reviewers have given it 4.9 stars on Google across 22 reviews beginning in 2024, 6 of them in the past year, and the themes that come up most are the staff (20 reviews) and the team's knowledge (10).

Services & access

Advertises semaglutide todayYes
Advertises tirzepatide todayYes
Telehealth visitsYes
Cash pay acceptedYes
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.9
Google rating · 22 reviews
6
reviews in the past year (avg ★ 4.7)
8
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-08-01. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.9 across 22 Google reviews. Of the 22 reviews we analyzed, 21 (95%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Friendly, helpful staff19 reviews
  • Knowledgeable, professional providers10 reviews
  • Weight-loss results9 reviews
  • Feeling listened to3 reviews

Common complaints

No negative reviews among those we analyzed.

5★
21
4★
0
3★
1
2★
0
1★
0

Most recent Google reviews

Nicole★★★★★2026-08-01

Everyone working there is incredibly sweet, nice, and professional. They remember your name and seem genuinely happy/excited for any and all changes in your life and health not just your weight. Would highly recommend to anyone who wants a weightliss journey with no pressure and caring people

L J.★★★★★2026-07-21

Based on several encounters with the front desk staff I’m not fully convinced that they are in tune with the full customer experience. When I questioned the next stage in my journey, I was told take your time and get back to us if you want to continue the program. Left me with the feeling as though I didn’t matter. Was never offered an option or guidance on how to proceed through the program.

Nadia C.★★★★★2026-06-30

I've had a good experience so far Kenya,Latesha,Leah and all the ladies there have been welcoming and helpful. I was nervous in this weight loss journey, thankfully they have made me feel safe and secure.

Marquetta B.★★★★★2026-06-05

Staff very knowledgeable, friendly and professional. Seeing progress in being in the program

Vern O.★★★★★2026-04-10

My local Medi staff is super friendly and are helpful and encouraging in my weight loss journey. Paris always greets with a smile and keeps you motivated to achieve your goals.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Chester

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs